Neurodegenerative Market Forecast to 2013Cutting Edge InformationFebruary 1, 2009 201 Pages - SKU: CIGQ2108024 |
| Which Alzheimer's blockbuster faces diminishing sales within the next decade? What has the potential to take its place? Which class of MS drugs is emerging as successful? What innovative treatments are on the horizon? Who is on track to become a market leader? Neurodegenerative Market Forecast to 2013 answers these questions - and much more - so you can navigate the still-uncharted market landscape with ease. This overview is comprehensive, covering only the most relevant information on Alzheimer's, MS and Parkinson's.....all in one place. With in-depth brand and drug class analyses, make research and spending decisions with the utmost confidence. Other reports skim the surface, examining only top drugs at top companies. Ours is complete, covering marketed brands, pipeline products, clinical development, and whole drug classes. Find all you need to tap into or maximize your presence in this lucrative space. |
Related Markets
CNS/Neurology Reports
- Traumatic Brain Injury Global Clinical Trials Review, H1, 2012
- Tension -Type Headache Global Clinical Trials Review, H1, 2012
- Cluster Headache Syndrome Global Clinical Trials Review, H1, 2012
- Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H1, 2012
- Brain Ischemia Global Clinical Trials Review, H1, 2012
